Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 7 studies | 21% ± 5% | |
epithelial cell | 4 studies | 19% ± 5% | |
adipocyte | 4 studies | 19% ± 2% | |
astrocyte | 4 studies | 33% ± 22% | |
glutamatergic neuron | 4 studies | 36% ± 12% | |
oligodendrocyte | 4 studies | 28% ± 9% | |
hepatocyte | 3 studies | 34% ± 19% | |
GABAergic neuron | 3 studies | 42% ± 5% | |
endothelial cell of lymphatic vessel | 3 studies | 18% ± 1% | |
neuron | 3 studies | 36% ± 17% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 34% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 909.98 | 1445 / 1445 | 100% | 8.25 | 183 / 183 |
liver | 100% | 632.72 | 226 / 226 | 100% | 9.05 | 406 / 406 |
pancreas | 100% | 796.68 | 328 / 328 | 100% | 11.84 | 178 / 178 |
stomach | 100% | 682.08 | 359 / 359 | 100% | 10.71 | 286 / 286 |
uterus | 100% | 894.12 | 170 / 170 | 100% | 14.30 | 459 / 459 |
intestine | 100% | 819.52 | 966 / 966 | 100% | 13.27 | 525 / 527 |
prostate | 100% | 701.50 | 244 / 245 | 100% | 12.72 | 502 / 502 |
breast | 100% | 774.98 | 459 / 459 | 100% | 9.68 | 1113 / 1118 |
ovary | 100% | 690.48 | 180 / 180 | 99% | 8.12 | 427 / 430 |
skin | 100% | 888.48 | 1807 / 1809 | 99% | 10.98 | 469 / 472 |
lung | 99% | 529.56 | 573 / 578 | 100% | 10.53 | 1154 / 1155 |
bladder | 100% | 1174.24 | 21 / 21 | 99% | 12.27 | 498 / 504 |
adrenal gland | 100% | 762.77 | 258 / 258 | 99% | 11.57 | 227 / 230 |
thymus | 99% | 425.42 | 646 / 653 | 100% | 8.97 | 602 / 605 |
brain | 98% | 383.62 | 2588 / 2642 | 100% | 7.37 | 705 / 705 |
kidney | 97% | 352.79 | 86 / 89 | 97% | 6.15 | 873 / 901 |
adipose | 100% | 894.10 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 12.89 | 29 / 29 |
muscle | 100% | 1244.61 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 452.72 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 12.80 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.04 | 1 / 1 |
blood vessel | 100% | 1488.97 | 1333 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 8.38 | 79 / 80 |
heart | 99% | 1031.43 | 849 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 60% | 287.26 | 561 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006915 | Biological process | apoptotic process |
GO_0010972 | Biological process | negative regulation of G2/M transition of mitotic cell cycle |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0012505 | Cellular component | endomembrane system |
GO_0005829 | Cellular component | cytosol |
GO_0016020 | Cellular component | membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | AVEN |
Protein name | Apoptosis and caspase activation inhibitor Cell death regulator Aven |
Synonyms | |
Description | FUNCTION: Protects against apoptosis mediated by Apaf-1. |
Accessions | ENST00000306730.8 H0YKR0 ENST00000560649.1 Q9NQS1 |